Predictors of Renal Outcome in HIV‐Associated Nephropathy
Author(s) -
Frank A. Post,
Lucy Campbell,
Lisa Hamzah,
Lisa Collins,
Rachael Jones,
Rizwan Siwani,
Leann Johnson,
Martin Fisher,
S. Holt,
Sanjay Bhagani,
Andrew Frankel,
Edmund Wilkins,
Jonathan Ainsworth,
N Larbalestier,
Derek C. Macallan,
Debasish Banerjee,
Guy Baily,
Raj Thuraisingham,
Paul Donohoe,
Bruce M. Hendry,
Rachel Hilton,
Simon Edwards,
Robert Hangartner,
Alexander J. Howie,
John O. Connolly,
Philippa Easterbrook
Publication year - 2008
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/529385
Subject(s) - medicine , renal function , nephropathy , kidney disease , population , renal biopsy , end stage renal disease , disease , gastroenterology , endocrinology , diabetes mellitus , environmental health
Human immunodeficiency virus (HIV)-associated nephropathy (HIVAN) is an important cause of end-stage renal disease among African American patients. This study was performed to study the epidemiology of HIVAN in a predominantly black African population and the impact of highly active antiretroviral therapy and other factors on the development of end-stage renal disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom